ARCHIVES

Emory Executive Objects to Report On Merit review

This article is from The Cancer Letter archive.

Vol. 03 No. 29 | July 22, 1977

Download PDF Visit The Full Archive

Related Articles

NCI To Study Whether It Gets The Most From Advisors.

March 8, 2002

The Administration: Gore Marks 2nd Year of Tumor Gene Index, Honors Armstrong, Cancer Survivors

September 3, 1999

NCI-Approved Clinical Trials

July 30, 2004

Avon, four companies Fund NABCO Patient Information Services

January 28, 1994

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

October 21, 2005

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007